Premier Anti-Aging Co., Ltd.
TSE:4934.T
735 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,790 | 5,385 | 5,264 | 5,790.842 | 6,351.107 | 6,867.112 | 7,391.604 | 8,015.012 | 7,926.751 | 8,104.39 | 9,865.75 | 9,048.186 | 8,455.343 | 8,098.311 | 7,210.9 | 5,933.037 |
| Cost of Revenue
| 923 | 1,090 | 1,070 | 2,232.948 | 1,834.595 | 1,445.73 | 1,644.503 | 2,047.925 | 1,764.414 | 1,529.078 | 1,941.531 | 1,855.821 | 1,567.936 | 1,429.441 | 1,529.655 | 1,284.647 |
| Gross Profit
| 3,867 | 4,295 | 4,194 | 3,557.894 | 4,516.512 | 5,421.382 | 5,747.101 | 5,967.087 | 6,162.337 | 6,575.312 | 7,924.219 | 7,192.365 | 6,887.407 | 6,668.87 | 5,681.245 | 4,648.39 |
| Gross Profit Ratio
| 0.807 | 0.798 | 0.797 | 0.614 | 0.711 | 0.789 | 0.778 | 0.744 | 0.777 | 0.811 | 0.803 | 0.795 | 0.815 | 0.823 | 0.788 | 0.783 |
| Reseach & Development Expenses
| 151 | 103 | 110 | 212.477 | 146.494 | 102.65 | 127.804 | 122.051 | 115.466 | 114.522 | 80.179 | 93.139 | 50.524 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | -4,598.353 | 0 | 0 | 0 | -7,531.792 | 0 | 0 | 0 | -5,964.781 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 8,598 | 0 | 0 | 0 | 12,920 | 0 | 0 | 0 | 12,812 | 0 | 0 | 0 | 0 |
| SG&A
| 3,508 | 4,361 | 4,120 | 3,999.647 | 4,436.504 | 4,965.404 | 5,863.591 | 5,388.208 | 6,337.759 | 6,287.209 | 5,769.242 | 6,847.219 | 4,859.033 | 0 | 0 | 0 |
| Other Expenses
| 5 | 2 | -4 | 2.371 | 14.566 | 2.882 | 2.635 | -25.293 | 21.616 | 4.089 | -0.723 | -12.259 | 0.082 | -2.954 | -17.293 | -2.091 |
| Operating Expenses
| 3,659 | 4,464 | 4,230 | 4,212.124 | 4,582.998 | 5,068.054 | 5,991.395 | 5,510.259 | 6,453.225 | 6,401.731 | 5,849.421 | 6,940.358 | 4,921.244 | 5,095.26 | 4,792.948 | 3,825.214 |
| Operating Income
| 208 | -169 | -35 | -654.228 | -66.487 | 353.328 | -244.294 | 456.828 | -290.889 | 173.582 | 2,074.797 | 252.008 | 1,966.162 | 1,573.61 | 888.296 | 823.175 |
| Operating Income Ratio
| 0.043 | -0.031 | -0.007 | -0.113 | -0.01 | 0.051 | -0.033 | 0.057 | -0.037 | 0.021 | 0.21 | 0.028 | 0.233 | 0.194 | 0.123 | 0.139 |
| Total Other Income Expenses Net
| 36 | -913 | 9 | -48.704 | 14.697 | -33.23 | 19.433 | -26.134 | 110.615 | 16.12 | 57.407 | -15.324 | -3.822 | 14.406 | -22.272 | -7.382 |
| Income Before Tax
| 244 | -1,082 | -26 | -702.932 | -51.79 | 320.098 | -224.861 | 430.694 | -180.274 | 189.702 | 2,132.204 | 236.684 | 1,962.34 | 1,588.016 | 866.024 | 815.793 |
| Income Before Tax Ratio
| 0.051 | -0.201 | -0.005 | -0.121 | -0.008 | 0.047 | -0.03 | 0.054 | -0.023 | 0.023 | 0.216 | 0.026 | 0.232 | 0.196 | 0.12 | 0.138 |
| Income Tax Expense
| 8 | 568 | 9 | -122.24 | 75.478 | 148.071 | -26.821 | 228.679 | -42.272 | 149.707 | 811.79 | 270.807 | 707.646 | 565.741 | 315.242 | 251.952 |
| Net Income
| 235 | -1,650 | -35 | -580.694 | -127.267 | 172.026 | -198.039 | 202.016 | -138.003 | 39.995 | 1,320.414 | -34.124 | 1,254.694 | 1,022.276 | 550.781 | 563.842 |
| Net Income Ratio
| 0.049 | -0.306 | -0.007 | -0.1 | -0.02 | 0.025 | -0.027 | 0.025 | -0.017 | 0.005 | 0.134 | -0.004 | 0.148 | 0.126 | 0.076 | 0.095 |
| EPS
| 26.95 | -189.21 | -4.01 | -66.59 | -14.59 | 19.73 | -22.71 | 23.17 | -15.82 | 4.58 | 151.43 | -3.91 | 145.34 | 119.29 | 68.52 | 64.81 |
| EPS Diluted
| 26.95 | -189.21 | -4.01 | -66.59 | -14.59 | 19.73 | -22.71 | 23.14 | -15.8 | 4.58 | 151.19 | -3.91 | 145.12 | 119.28 | 68.25 | 64.81 |
| EBITDA
| 282 | -130 | -21 | -648.329 | -45.953 | 323.624 | -221.778 | 433.899 | -177.34 | 194.129 | 2,100.824 | 240.004 | 1,966.265 | 1,590.701 | 871.012 | 821.083 |
| EBITDA Ratio
| 0.059 | -0.024 | -0.004 | -0.112 | -0.007 | 0.047 | -0.03 | 0.054 | -0.022 | 0.024 | 0.213 | 0.027 | 0.233 | 0.196 | 0.121 | 0.138 |